And when filmmakers aren’t sanitizing the experience or staying within the boundaries of mainstream acceptability, you get an ...

Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount of weight, the company said.

A new Ozempic-like pill has led to “significant” weight-loss in a major trial, paving the way for a new era of obesity treatment.

New weight loss pill more ‘tolerable’ than jabs shown to be effective in key trial The tablet could be a cheaper and more convenient alternative to injections ...

I lost 10 stone without weight-loss jabs. Here's how I did it Lisa Bernett went from a size 24 to a size 8 in two years with some very actionable – and affordable – changes to her diet and lifestyle.

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.

Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight loss like Ozempic. Here's the deal.

Eli Lilly's oral GLP-1 drug orforglipron shows promise in weight loss, with significant results in a 72-week trial, aiming for 2025 global approval.

Eli Lilly’s experimental oral weight loss pill helped patients lose about 12 percent of their body weight on average in a late-stage trial, the company said Thursday, positive results but still ...

The experimental obesity medicine is one of two that could offer alternatives to weight-loss injections within the next year or so.

Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight in a late-stage study, but that was less than previous trial results for Novo Nordisk's ...